Infectious Vaccines Market, Global Outlook and Forecast 2022-2028
A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
This report contains market size and forecasts of Infectious Vaccines in global, including the following market information:
Global Infectious Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Infectious Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Infectious Vaccines companies in 2021 (%)
The global Infectious Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Preventive Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Vaccines include CSL Limited (Australia), Bavarian Nordic (Denmark), GlaxoSmithKline plc. (U.K.), Emergent Bio Solutions Inc. (U.S.), MedImmune LLC (U.S.), Johnson and Johnson (U.S.), Novartis AG (Switzerland), Merck and Company (U.S.) and Sanofi Pasteur (France) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Vaccines Market Segment Percentages, by Type, 2021 (%)
Global Infectious Vaccines Market Segment Percentages, by Application, 2021 (%)
Global Infectious Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Infectious Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Infectious Vaccines revenues share in global market, 2021 (%)
Key companies Infectious Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Infectious Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Infectious Vaccines in global, including the following market information:
Global Infectious Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Infectious Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Infectious Vaccines companies in 2021 (%)
The global Infectious Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Preventive Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Vaccines include CSL Limited (Australia), Bavarian Nordic (Denmark), GlaxoSmithKline plc. (U.K.), Emergent Bio Solutions Inc. (U.S.), MedImmune LLC (U.S.), Johnson and Johnson (U.S.), Novartis AG (Switzerland), Merck and Company (U.S.) and Sanofi Pasteur (France) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Vaccines Market Segment Percentages, by Type, 2021 (%)
- Preventive Vaccine
- Therapeutic Vaccine
Global Infectious Vaccines Market Segment Percentages, by Application, 2021 (%)
- Adults
- Pediatrics
Global Infectious Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Infectious Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Infectious Vaccines revenues share in global market, 2021 (%)
Key companies Infectious Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Infectious Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- CSL Limited (Australia)
- Bavarian Nordic (Denmark)
- GlaxoSmithKline plc. (U.K.)
- Emergent Bio Solutions Inc. (U.S.)
- MedImmune LLC (U.S.)
- Johnson and Johnson (U.S.)
- Novartis AG (Switzerland)
- Merck and Company (U.S.)
- Sanofi Pasteur (France)
- Pfizer Inc. (U.S.)
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Infectious Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INFECTIOUS VACCINES OVERALL MARKET SIZE
2.1 Global Infectious Vaccines Market Size: 2021 VS 2028
2.2 Global Infectious Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Infectious Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Infectious Vaccines Players in Global Market
3.2 Top Global Infectious Vaccines Companies Ranked by Revenue
3.3 Global Infectious Vaccines Revenue by Companies
3.4 Global Infectious Vaccines Sales by Companies
3.5 Global Infectious Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Infectious Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Infectious Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Infectious Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Infectious Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Infectious Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Infectious Vaccines Market Size Markets, 2021 & 2028
4.1.2 Preventive Vaccine
4.1.3 Therapeutic Vaccine
4.2 By Type - Global Infectious Vaccines Revenue & Forecasts
4.2.1 By Type - Global Infectious Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Infectious Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Infectious Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Infectious Vaccines Sales & Forecasts
4.3.1 By Type - Global Infectious Vaccines Sales, 2017-2022
4.3.2 By Type - Global Infectious Vaccines Sales, 2023-2028
4.3.3 By Type - Global Infectious Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Infectious Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Infectious Vaccines Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Pediatrics
5.2 By Application - Global Infectious Vaccines Revenue & Forecasts
5.2.1 By Application - Global Infectious Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Infectious Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Infectious Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Infectious Vaccines Sales & Forecasts
5.3.1 By Application - Global Infectious Vaccines Sales, 2017-2022
5.3.2 By Application - Global Infectious Vaccines Sales, 2023-2028
5.3.3 By Application - Global Infectious Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Infectious Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Infectious Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Infectious Vaccines Revenue & Forecasts
6.2.1 By Region - Global Infectious Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Infectious Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Infectious Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Infectious Vaccines Sales & Forecasts
6.3.1 By Region - Global Infectious Vaccines Sales, 2017-2022
6.3.2 By Region - Global Infectious Vaccines Sales, 2023-2028
6.3.3 By Region - Global Infectious Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Infectious Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Infectious Vaccines Sales, 2017-2028
6.4.3 US Infectious Vaccines Market Size, 2017-2028
6.4.4 Canada Infectious Vaccines Market Size, 2017-2028
6.4.5 Mexico Infectious Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Infectious Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Infectious Vaccines Sales, 2017-2028
6.5.3 Germany Infectious Vaccines Market Size, 2017-2028
6.5.4 France Infectious Vaccines Market Size, 2017-2028
6.5.5 U.K. Infectious Vaccines Market Size, 2017-2028
6.5.6 Italy Infectious Vaccines Market Size, 2017-2028
6.5.7 Russia Infectious Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Infectious Vaccines Market Size, 2017-2028
6.5.9 Benelux Infectious Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Infectious Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Infectious Vaccines Sales, 2017-2028
6.6.3 China Infectious Vaccines Market Size, 2017-2028
6.6.4 Japan Infectious Vaccines Market Size, 2017-2028
6.6.5 South Korea Infectious Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Infectious Vaccines Market Size, 2017-2028
6.6.7 India Infectious Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Infectious Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Infectious Vaccines Sales, 2017-2028
6.7.3 Brazil Infectious Vaccines Market Size, 2017-2028
6.7.4 Argentina Infectious Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Infectious Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Infectious Vaccines Sales, 2017-2028
6.8.3 Turkey Infectious Vaccines Market Size, 2017-2028
6.8.4 Israel Infectious Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Infectious Vaccines Market Size, 2017-2028
6.8.6 UAE Infectious Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 CSL Limited (Australia)
7.1.1 CSL Limited (Australia) Corporate Summary
7.1.2 CSL Limited (Australia) Business Overview
7.1.3 CSL Limited (Australia) Infectious Vaccines Major Product Offerings
7.1.4 CSL Limited (Australia) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 CSL Limited (Australia) Key News
7.2 Bavarian Nordic (Denmark)
7.2.1 Bavarian Nordic (Denmark) Corporate Summary
7.2.2 Bavarian Nordic (Denmark) Business Overview
7.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Major Product Offerings
7.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Bavarian Nordic (Denmark) Key News
7.3 GlaxoSmithKline plc. (U.K.)
7.3.1 GlaxoSmithKline plc. (U.K.) Corporate Summary
7.3.2 GlaxoSmithKline plc. (U.K.) Business Overview
7.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Major Product Offerings
7.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline plc. (U.K.) Key News
7.4 Emergent Bio Solutions Inc. (U.S.)
7.4.1 Emergent Bio Solutions Inc. (U.S.) Corporate Summary
7.4.2 Emergent Bio Solutions Inc. (U.S.) Business Overview
7.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Major Product Offerings
7.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Emergent Bio Solutions Inc. (U.S.) Key News
7.5 MedImmune LLC (U.S.)
7.5.1 MedImmune LLC (U.S.) Corporate Summary
7.5.2 MedImmune LLC (U.S.) Business Overview
7.5.3 MedImmune LLC (U.S.) Infectious Vaccines Major Product Offerings
7.5.4 MedImmune LLC (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 MedImmune LLC (U.S.) Key News
7.6 Johnson and Johnson (U.S.)
7.6.1 Johnson and Johnson (U.S.) Corporate Summary
7.6.2 Johnson and Johnson (U.S.) Business Overview
7.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Major Product Offerings
7.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Johnson and Johnson (U.S.) Key News
7.7 Novartis AG (Switzerland)
7.7.1 Novartis AG (Switzerland) Corporate Summary
7.7.2 Novartis AG (Switzerland) Business Overview
7.7.3 Novartis AG (Switzerland) Infectious Vaccines Major Product Offerings
7.7.4 Novartis AG (Switzerland) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Novartis AG (Switzerland) Key News
7.8 Merck and Company (U.S.)
7.8.1 Merck and Company (U.S.) Corporate Summary
7.8.2 Merck and Company (U.S.) Business Overview
7.8.3 Merck and Company (U.S.) Infectious Vaccines Major Product Offerings
7.8.4 Merck and Company (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Merck and Company (U.S.) Key News
7.9 Sanofi Pasteur (France)
7.9.1 Sanofi Pasteur (France) Corporate Summary
7.9.2 Sanofi Pasteur (France) Business Overview
7.9.3 Sanofi Pasteur (France) Infectious Vaccines Major Product Offerings
7.9.4 Sanofi Pasteur (France) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Sanofi Pasteur (France) Key News
7.10 Pfizer Inc. (U.S.)
7.10.1 Pfizer Inc. (U.S.) Corporate Summary
7.10.2 Pfizer Inc. (U.S.) Business Overview
7.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Major Product Offerings
7.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Inc. (U.S.) Key News
8 GLOBAL INFECTIOUS VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Infectious Vaccines Production Capacity, 2017-2028
8.2 Infectious Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Infectious Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INFECTIOUS VACCINES SUPPLY CHAIN ANALYSIS
10.1 Infectious Vaccines Industry Value Chain
10.2 Infectious Vaccines Upstream Market
10.3 Infectious Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Infectious Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Infectious Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INFECTIOUS VACCINES OVERALL MARKET SIZE
2.1 Global Infectious Vaccines Market Size: 2021 VS 2028
2.2 Global Infectious Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Infectious Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Infectious Vaccines Players in Global Market
3.2 Top Global Infectious Vaccines Companies Ranked by Revenue
3.3 Global Infectious Vaccines Revenue by Companies
3.4 Global Infectious Vaccines Sales by Companies
3.5 Global Infectious Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Infectious Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Infectious Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Infectious Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Infectious Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Infectious Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Infectious Vaccines Market Size Markets, 2021 & 2028
4.1.2 Preventive Vaccine
4.1.3 Therapeutic Vaccine
4.2 By Type - Global Infectious Vaccines Revenue & Forecasts
4.2.1 By Type - Global Infectious Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Infectious Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Infectious Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Infectious Vaccines Sales & Forecasts
4.3.1 By Type - Global Infectious Vaccines Sales, 2017-2022
4.3.2 By Type - Global Infectious Vaccines Sales, 2023-2028
4.3.3 By Type - Global Infectious Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Infectious Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Infectious Vaccines Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Pediatrics
5.2 By Application - Global Infectious Vaccines Revenue & Forecasts
5.2.1 By Application - Global Infectious Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Infectious Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Infectious Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Infectious Vaccines Sales & Forecasts
5.3.1 By Application - Global Infectious Vaccines Sales, 2017-2022
5.3.2 By Application - Global Infectious Vaccines Sales, 2023-2028
5.3.3 By Application - Global Infectious Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Infectious Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Infectious Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Infectious Vaccines Revenue & Forecasts
6.2.1 By Region - Global Infectious Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Infectious Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Infectious Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Infectious Vaccines Sales & Forecasts
6.3.1 By Region - Global Infectious Vaccines Sales, 2017-2022
6.3.2 By Region - Global Infectious Vaccines Sales, 2023-2028
6.3.3 By Region - Global Infectious Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Infectious Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Infectious Vaccines Sales, 2017-2028
6.4.3 US Infectious Vaccines Market Size, 2017-2028
6.4.4 Canada Infectious Vaccines Market Size, 2017-2028
6.4.5 Mexico Infectious Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Infectious Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Infectious Vaccines Sales, 2017-2028
6.5.3 Germany Infectious Vaccines Market Size, 2017-2028
6.5.4 France Infectious Vaccines Market Size, 2017-2028
6.5.5 U.K. Infectious Vaccines Market Size, 2017-2028
6.5.6 Italy Infectious Vaccines Market Size, 2017-2028
6.5.7 Russia Infectious Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Infectious Vaccines Market Size, 2017-2028
6.5.9 Benelux Infectious Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Infectious Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Infectious Vaccines Sales, 2017-2028
6.6.3 China Infectious Vaccines Market Size, 2017-2028
6.6.4 Japan Infectious Vaccines Market Size, 2017-2028
6.6.5 South Korea Infectious Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Infectious Vaccines Market Size, 2017-2028
6.6.7 India Infectious Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Infectious Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Infectious Vaccines Sales, 2017-2028
6.7.3 Brazil Infectious Vaccines Market Size, 2017-2028
6.7.4 Argentina Infectious Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Infectious Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Infectious Vaccines Sales, 2017-2028
6.8.3 Turkey Infectious Vaccines Market Size, 2017-2028
6.8.4 Israel Infectious Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Infectious Vaccines Market Size, 2017-2028
6.8.6 UAE Infectious Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 CSL Limited (Australia)
7.1.1 CSL Limited (Australia) Corporate Summary
7.1.2 CSL Limited (Australia) Business Overview
7.1.3 CSL Limited (Australia) Infectious Vaccines Major Product Offerings
7.1.4 CSL Limited (Australia) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 CSL Limited (Australia) Key News
7.2 Bavarian Nordic (Denmark)
7.2.1 Bavarian Nordic (Denmark) Corporate Summary
7.2.2 Bavarian Nordic (Denmark) Business Overview
7.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Major Product Offerings
7.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Bavarian Nordic (Denmark) Key News
7.3 GlaxoSmithKline plc. (U.K.)
7.3.1 GlaxoSmithKline plc. (U.K.) Corporate Summary
7.3.2 GlaxoSmithKline plc. (U.K.) Business Overview
7.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Major Product Offerings
7.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline plc. (U.K.) Key News
7.4 Emergent Bio Solutions Inc. (U.S.)
7.4.1 Emergent Bio Solutions Inc. (U.S.) Corporate Summary
7.4.2 Emergent Bio Solutions Inc. (U.S.) Business Overview
7.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Major Product Offerings
7.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Emergent Bio Solutions Inc. (U.S.) Key News
7.5 MedImmune LLC (U.S.)
7.5.1 MedImmune LLC (U.S.) Corporate Summary
7.5.2 MedImmune LLC (U.S.) Business Overview
7.5.3 MedImmune LLC (U.S.) Infectious Vaccines Major Product Offerings
7.5.4 MedImmune LLC (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 MedImmune LLC (U.S.) Key News
7.6 Johnson and Johnson (U.S.)
7.6.1 Johnson and Johnson (U.S.) Corporate Summary
7.6.2 Johnson and Johnson (U.S.) Business Overview
7.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Major Product Offerings
7.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Johnson and Johnson (U.S.) Key News
7.7 Novartis AG (Switzerland)
7.7.1 Novartis AG (Switzerland) Corporate Summary
7.7.2 Novartis AG (Switzerland) Business Overview
7.7.3 Novartis AG (Switzerland) Infectious Vaccines Major Product Offerings
7.7.4 Novartis AG (Switzerland) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Novartis AG (Switzerland) Key News
7.8 Merck and Company (U.S.)
7.8.1 Merck and Company (U.S.) Corporate Summary
7.8.2 Merck and Company (U.S.) Business Overview
7.8.3 Merck and Company (U.S.) Infectious Vaccines Major Product Offerings
7.8.4 Merck and Company (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Merck and Company (U.S.) Key News
7.9 Sanofi Pasteur (France)
7.9.1 Sanofi Pasteur (France) Corporate Summary
7.9.2 Sanofi Pasteur (France) Business Overview
7.9.3 Sanofi Pasteur (France) Infectious Vaccines Major Product Offerings
7.9.4 Sanofi Pasteur (France) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Sanofi Pasteur (France) Key News
7.10 Pfizer Inc. (U.S.)
7.10.1 Pfizer Inc. (U.S.) Corporate Summary
7.10.2 Pfizer Inc. (U.S.) Business Overview
7.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Major Product Offerings
7.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Inc. (U.S.) Key News
8 GLOBAL INFECTIOUS VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Infectious Vaccines Production Capacity, 2017-2028
8.2 Infectious Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Infectious Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INFECTIOUS VACCINES SUPPLY CHAIN ANALYSIS
10.1 Infectious Vaccines Industry Value Chain
10.2 Infectious Vaccines Upstream Market
10.3 Infectious Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Infectious Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Infectious Vaccines in Global Market
Table 2. Top Infectious Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Infectious Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Infectious Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Infectious Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Infectious Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Infectious Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Infectious Vaccines Product Type
Table 9. List of Global Tier 1 Infectious Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Infectious Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Infectious Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Infectious Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Infectious Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Infectious Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Infectious Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Infectious Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Infectious Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Infectious Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Infectious Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Infectious Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Infectious Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Infectious Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Infectious Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Infectious Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Infectious Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Infectious Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Infectious Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Infectious Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Infectious Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Infectious Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Infectious Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Infectious Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Infectious Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Infectious Vaccines Sales, (K Units), 2023-2028
Table 46. CSL Limited (Australia) Corporate Summary
Table 47. CSL Limited (Australia) Infectious Vaccines Product Offerings
Table 48. CSL Limited (Australia) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Bavarian Nordic (Denmark) Corporate Summary
Table 50. Bavarian Nordic (Denmark) Infectious Vaccines Product Offerings
Table 51. Bavarian Nordic (Denmark) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. GlaxoSmithKline plc. (U.K.) Corporate Summary
Table 53. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Offerings
Table 54. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Emergent Bio Solutions Inc. (U.S.) Corporate Summary
Table 56. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Offerings
Table 57. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. MedImmune LLC (U.S.) Corporate Summary
Table 59. MedImmune LLC (U.S.) Infectious Vaccines Product Offerings
Table 60. MedImmune LLC (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Johnson and Johnson (U.S.) Corporate Summary
Table 62. Johnson and Johnson (U.S.) Infectious Vaccines Product Offerings
Table 63. Johnson and Johnson (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Novartis AG (Switzerland) Corporate Summary
Table 65. Novartis AG (Switzerland) Infectious Vaccines Product Offerings
Table 66. Novartis AG (Switzerland) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Merck and Company (U.S.) Corporate Summary
Table 68. Merck and Company (U.S.) Infectious Vaccines Product Offerings
Table 69. Merck and Company (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Sanofi Pasteur (France) Corporate Summary
Table 71. Sanofi Pasteur (France) Infectious Vaccines Product Offerings
Table 72. Sanofi Pasteur (France) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Pfizer Inc. (U.S.) Corporate Summary
Table 74. Pfizer Inc. (U.S.) Infectious Vaccines Product Offerings
Table 75. Pfizer Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Infectious Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Infectious Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Infectious Vaccines Production by Region, 2017-2022 (K Units)
Table 79. Global Infectious Vaccines Production by Region, 2023-2028 (K Units)
Table 80. Infectious Vaccines Market Opportunities & Trends in Global Market
Table 81. Infectious Vaccines Market Drivers in Global Market
Table 82. Infectious Vaccines Market Restraints in Global Market
Table 83. Infectious Vaccines Raw Materials
Table 84. Infectious Vaccines Raw Materials Suppliers in Global Market
Table 85. Typical Infectious Vaccines Downstream
Table 86. Infectious Vaccines Downstream Clients in Global Market
Table 87. Infectious Vaccines Distributors and Sales Agents in Global Market
Table 1. Key Players of Infectious Vaccines in Global Market
Table 2. Top Infectious Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Infectious Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Infectious Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Infectious Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Infectious Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Infectious Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Infectious Vaccines Product Type
Table 9. List of Global Tier 1 Infectious Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Infectious Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Infectious Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Infectious Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Infectious Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Infectious Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Infectious Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Infectious Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Infectious Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Infectious Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Infectious Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Infectious Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Infectious Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Infectious Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Infectious Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Infectious Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Infectious Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Infectious Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Infectious Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Infectious Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Infectious Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Infectious Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Infectious Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Infectious Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Infectious Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Infectious Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Infectious Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Infectious Vaccines Sales, (K Units), 2023-2028
Table 46. CSL Limited (Australia) Corporate Summary
Table 47. CSL Limited (Australia) Infectious Vaccines Product Offerings
Table 48. CSL Limited (Australia) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Bavarian Nordic (Denmark) Corporate Summary
Table 50. Bavarian Nordic (Denmark) Infectious Vaccines Product Offerings
Table 51. Bavarian Nordic (Denmark) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. GlaxoSmithKline plc. (U.K.) Corporate Summary
Table 53. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Offerings
Table 54. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Emergent Bio Solutions Inc. (U.S.) Corporate Summary
Table 56. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Offerings
Table 57. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. MedImmune LLC (U.S.) Corporate Summary
Table 59. MedImmune LLC (U.S.) Infectious Vaccines Product Offerings
Table 60. MedImmune LLC (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Johnson and Johnson (U.S.) Corporate Summary
Table 62. Johnson and Johnson (U.S.) Infectious Vaccines Product Offerings
Table 63. Johnson and Johnson (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Novartis AG (Switzerland) Corporate Summary
Table 65. Novartis AG (Switzerland) Infectious Vaccines Product Offerings
Table 66. Novartis AG (Switzerland) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Merck and Company (U.S.) Corporate Summary
Table 68. Merck and Company (U.S.) Infectious Vaccines Product Offerings
Table 69. Merck and Company (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Sanofi Pasteur (France) Corporate Summary
Table 71. Sanofi Pasteur (France) Infectious Vaccines Product Offerings
Table 72. Sanofi Pasteur (France) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Pfizer Inc. (U.S.) Corporate Summary
Table 74. Pfizer Inc. (U.S.) Infectious Vaccines Product Offerings
Table 75. Pfizer Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Infectious Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Infectious Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Infectious Vaccines Production by Region, 2017-2022 (K Units)
Table 79. Global Infectious Vaccines Production by Region, 2023-2028 (K Units)
Table 80. Infectious Vaccines Market Opportunities & Trends in Global Market
Table 81. Infectious Vaccines Market Drivers in Global Market
Table 82. Infectious Vaccines Market Restraints in Global Market
Table 83. Infectious Vaccines Raw Materials
Table 84. Infectious Vaccines Raw Materials Suppliers in Global Market
Table 85. Typical Infectious Vaccines Downstream
Table 86. Infectious Vaccines Downstream Clients in Global Market
Table 87. Infectious Vaccines Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Infectious Vaccines Segment by Type
Figure 2. Infectious Vaccines Segment by Application
Figure 3. Global Infectious Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Infectious Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Infectious Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Infectious Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Infectious Vaccines Revenue in 2021
Figure 9. By Type - Global Infectious Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Infectious Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Infectious Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Infectious Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Infectious Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Infectious Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Infectious Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Infectious Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Infectious Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Infectious Vaccines Sales Market Share, 2017-2028
Figure 19. US Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Infectious Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Infectious Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Infectious Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Infectious Vaccines Sales Market Share, 2017-2028
Figure 33. China Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Infectious Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Infectious Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Infectious Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Infectious Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Infectious Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Infectious Vaccines by Region, 2021 VS 2028
Figure 50. Infectious Vaccines Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Infectious Vaccines Segment by Type
Figure 2. Infectious Vaccines Segment by Application
Figure 3. Global Infectious Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Infectious Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Infectious Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Infectious Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Infectious Vaccines Revenue in 2021
Figure 9. By Type - Global Infectious Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Infectious Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Infectious Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Infectious Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Infectious Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Infectious Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Infectious Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Infectious Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Infectious Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Infectious Vaccines Sales Market Share, 2017-2028
Figure 19. US Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Infectious Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Infectious Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Infectious Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Infectious Vaccines Sales Market Share, 2017-2028
Figure 33. China Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Infectious Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Infectious Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Infectious Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Infectious Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Infectious Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Infectious Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Infectious Vaccines by Region, 2021 VS 2028
Figure 50. Infectious Vaccines Industry Value Chain
Figure 51. Marketing Channels
